Growth Metrics

Gilead Sciences (GILD) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $12.8 billion.

  • Gilead Sciences' Retained Earnings rose 1582.23% to $12.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 billion, marking a year-over-year increase of 1582.23%. This contributed to the annual value of $11.5 billion for FY2024, which is 2948.36% down from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Retained Earnings is $12.8 billion, which was up 1582.23% from $11.3 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Retained Earnings ranged from a high of $16.9 billion in Q3 2021 and a low of $10.7 billion during Q1 2024
  • For the 5-year period, Gilead Sciences' Retained Earnings averaged around $14.1 billion, with its median value being $15.1 billion (2022).
  • As far as peak fluctuations go, Gilead Sciences' Retained Earnings surged by 2329.86% in 2021, and later tumbled by 3080.24% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Retained Earnings stood at $16.3 billion in 2021, then dropped by 3.9% to $15.7 billion in 2022, then grew by 3.93% to $16.3 billion in 2023, then decreased by 29.48% to $11.5 billion in 2024, then rose by 11.55% to $12.8 billion in 2025.
  • Its Retained Earnings was $12.8 billion in Q3 2025, compared to $11.3 billion in Q2 2025 and $10.9 billion in Q1 2025.